76 related articles for article (PubMed ID: 20694663)
1. Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1.
Ma RY; Tong TH; Leung WY; Yao KM
Methods Mol Biol; 2010; 647():113-23. PubMed ID: 20694663
[TBL] [Abstract][Full Text] [Related]
2. Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c.
Ma RY; Tong TH; Cheung AM; Tsang AC; Leung WY; Yao KM
J Cell Sci; 2005 Feb; 118(Pt 4):795-806. PubMed ID: 15671063
[TBL] [Abstract][Full Text] [Related]
3. [Effects of extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activation on proliferation and cell cycle associated genes in human colon cancer cells].
Wang X; Lu R; Fang JY
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):982-6. PubMed ID: 17650425
[TBL] [Abstract][Full Text] [Related]
4. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
[TBL] [Abstract][Full Text] [Related]
5. Estrogens do not modify MAP kinase-dependent nuclear signaling during stimulation of early G(1) progression in human breast cancer cells.
Caristi S; Galera JL; Matarese F; Imai M; Caporali S; Cancemi M; Altucci L; Cicatiello L; Teti D; Bresciani F; Weisz A
Cancer Res; 2001 Sep; 61(17):6360-6. PubMed ID: 11522626
[TBL] [Abstract][Full Text] [Related]
6. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
Franklin CC; Kraft AS
Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
[TBL] [Abstract][Full Text] [Related]
7. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
10. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
11. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade.
Pleschka S; Wolff T; Ehrhardt C; Hobom G; Planz O; Rapp UR; Ludwig S
Nat Cell Biol; 2001 Mar; 3(3):301-5. PubMed ID: 11231581
[TBL] [Abstract][Full Text] [Related]
12. MEK/ERK signaling controls osmoregulation of nucleus pulposus cells of the intervertebral disc by transactivation of TonEBP/OREBP.
Tsai TT; Guttapalli A; Agrawal A; Albert TJ; Shapiro IM; Risbud MV
J Bone Miner Res; 2007 Jul; 22(7):965-74. PubMed ID: 17371162
[TBL] [Abstract][Full Text] [Related]
13. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.
Roberts PJ; Der CJ
Oncogene; 2007 May; 26(22):3291-310. PubMed ID: 17496923
[TBL] [Abstract][Full Text] [Related]
14. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation.
Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3091-8. PubMed ID: 12202534
[TBL] [Abstract][Full Text] [Related]
15. E2F5 and LEK1 translocation to the nucleus is an early event demarcating myoblast quiescence.
Reed SA; Ouellette SE; Liu X; Allen RE; Johnson SE
J Cell Biochem; 2007 Aug; 101(6):1394-408. PubMed ID: 17295207
[TBL] [Abstract][Full Text] [Related]
16. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
17. Deciphering signaling pathways in vivo: the Ras/Raf/MEK/ERK cascade.
Galabova-Kovacs G; Baccarini M
Methods Mol Biol; 2010; 661():421-31. PubMed ID: 20811999
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase D3 sensitizes RAF inhibitor RAF265 in melanoma cells by preventing reactivation of MAPK signaling.
Chen J; Shen Q; Labow M; Gaither LA
Cancer Res; 2011 Jun; 71(12):4280-91. PubMed ID: 21527556
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional activation of the mouse Necl-5/Tage4/PVR/CD155 gene by fibroblast growth factor or oncogenic Ras through the Raf-MEK-ERK-AP-1 pathway.
Hirota T; Irie K; Okamoto R; Ikeda W; Takai Y
Oncogene; 2005 Mar; 24(13):2229-35. PubMed ID: 15688018
[TBL] [Abstract][Full Text] [Related]
20. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
Lee M
Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]